Matthew R. Rowe

516 total citations
8 papers, 318 citations indexed

About

Matthew R. Rowe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Matthew R. Rowe has authored 8 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Matthew R. Rowe's work include Mitochondrial Function and Pathology (2 papers), Metabolism and Genetic Disorders (2 papers) and Microtubule and mitosis dynamics (2 papers). Matthew R. Rowe is often cited by papers focused on Mitochondrial Function and Pathology (2 papers), Metabolism and Genetic Disorders (2 papers) and Microtubule and mitosis dynamics (2 papers). Matthew R. Rowe collaborates with scholars based in New Zealand, United States and Canada. Matthew R. Rowe's co-authors include Michael V. Berridge, Patries M. Herst, Melanie J. McConnell, Rémi Schneider, Matthew Lee, Jeff Bruce, Shi‐Jun Yue, Fei‐Fei Liu, Peter R. Shepherd and Kenneth W. Yip and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Cancer Letters.

In The Last Decade

Matthew R. Rowe

7 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew R. Rowe New Zealand 6 226 74 36 34 30 8 318
Yuxiang Zheng United States 6 232 1.0× 74 1.0× 46 1.3× 40 1.2× 34 1.1× 12 421
Gina C. Bardwell United States 2 330 1.5× 73 1.0× 55 1.5× 49 1.4× 28 0.9× 2 410
Cristina Núñez de Arenas Spain 9 297 1.3× 83 1.1× 34 0.9× 39 1.1× 19 0.6× 12 432
Xin Cai China 7 180 0.8× 62 0.8× 33 0.9× 22 0.6× 20 0.7× 12 286
Anastasia A. Khutornenko Russia 10 345 1.5× 99 1.3× 28 0.8× 47 1.4× 29 1.0× 13 465
Anjaneyulu Murari United States 11 289 1.3× 43 0.6× 26 0.7× 29 0.9× 30 1.0× 14 414
Dhruv Gohel India 12 236 1.0× 65 0.9× 16 0.4× 41 1.2× 13 0.4× 21 337
Dinesh Babu Uthaya Kumar United States 10 221 1.0× 93 1.3× 57 1.6× 65 1.9× 18 0.6× 21 411
Rishi Banerjee Finland 5 323 1.4× 71 1.0× 25 0.7× 15 0.4× 12 0.4× 6 411
Joanna Bons United States 12 166 0.7× 30 0.4× 56 1.6× 44 1.3× 18 0.6× 38 349

Countries citing papers authored by Matthew R. Rowe

Since Specialization
Citations

This map shows the geographic impact of Matthew R. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew R. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew R. Rowe more than expected).

Fields of papers citing papers by Matthew R. Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew R. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew R. Rowe. The network helps show where Matthew R. Rowe may publish in the future.

Co-authorship network of co-authors of Matthew R. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew R. Rowe. A scholar is included among the top collaborators of Matthew R. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew R. Rowe. Matthew R. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Slatter, Tania L., Sam Lee, M. Leticia Castro, et al.. (2020). The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy. PLoS ONE. 15(4). e0231470–e0231470. 11 indexed citations
2.
Field, Jessica J., A. Jonathan Singh, Saptarshi Sinha, et al.. (2018). Synthesis and Microtubule‐Destabilizing Activity of N‐Cyclopropyl‐4‐((3,4‐dihydroquinolin‐1(2H)‐yl)sulfonyl)benzamide and its Analogs. Chemistry - An Asian Journal. 14(8). 1151–1157.
3.
Berridge, Michael V., Patries M. Herst, Matthew R. Rowe, Rémi Schneider, & Melanie J. McConnell. (2017). Mitochondrial transfer between cells: Methodological constraints in cell culture and animal models. Analytical Biochemistry. 552. 75–80. 25 indexed citations
4.
Herst, Patries M., et al.. (2017). Functional Mitochondria in Health and Disease. Frontiers in Endocrinology. 8. 296–296. 203 indexed citations
5.
Shi, Wei, Jeff Bruce, Matthew Lee, et al.. (2016). MiR-449a promotes breast cancer progression by targeting CRIP2. Oncotarget. 7(14). 18906–18918. 48 indexed citations
6.
Rowe, Matthew R., et al.. (2016). Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models. International Journal of Oncology. 49(1). 207–216. 14 indexed citations
7.
Kanakkanthara, Arun, Matthew R. Rowe, Jessica J. Field, et al.. (2015). βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug–tubulin interactions and microtubule stability. Cancer Letters. 365(2). 251–260. 16 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026